Implanet S.A. (EPA:ALIMP)
France
· Delayed Price · Currency is EUR 0.202
+0.002 (1.00%)
Apr 28, 2026, 4:00 PM CET
Implanet Revenue
In the year 2025, Implanet had annual revenue of 12.47M EUR with 32.62% growth. Implanet had revenue of 6.67M in the half year ending December 31, 2025, with 109.66% growth.
Revenue
12.47M
Revenue Growth
+32.62%
P/S Ratio
2.33
Revenue / Employee
271.17K
Employees
46
Market Cap
29.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 12.47M | 3.07M | 32.62% |
| Dec 31, 2024 | 9.41M | 1.96M | 26.31% |
| Dec 31, 2023 | 7.45M | -581.00K | -7.24% |
| Dec 31, 2022 | 8.03M | 1.89M | 30.75% |
| Dec 31, 2021 | 6.14M | 2.25M | 57.76% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Theraclion | 2.32M |
| Novacyt | 22.69M |
| Diagnostic Medical Systems | 49.47M |
| Ikonisys | 1.47M |
| Mauna Kea Technologies | 8.91M |
| Biosynex | 97.95M |
| SpineGuard | 3.76M |
| Bluelinea Société Anonyme | 11.68M |